Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, D.
Right arrow Articles by Brunengraber, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, D.
Right arrow Articles by Brunengraber, H.
(Journal of Nutrition. 2000;130:991S-994S.)
© 2000 The American Society for Nutritional Sciences


Supplement

Glutamate, a Window on Liver Intermediary Metabolism1 ,2

Dawei Yang and Henri Brunengraber3

Department of Nutrition, Case Western Reserve University, Cleveland, OH 44106

3To whom correspondence should be addressed.

In isotopic experiments, the labeling pattern of glutamate opens a window on hepatic metabolism, particularly the citric acid cycle, gluconeogenesis and fatty acid oxidation. This is because glutamate is in isotopic equilibrium with {alpha}-ketoglutarate, whose labeling pattern is influenced by the following: 1) the contributions of glucose and fatty acids to acetyl-CoA, 2) the relative contributions of pyruvate carboxylase and pyruvate dehydrogenase to the entry of pyruvate carbon into the citric acid cycle, and 3) the rate of gluconeogenesis in relation to citric acid cycle activity. In humans and primates, hepatic glutamate can be sampled noninvasively via urinary phenylacetylglutamine, which is formed in liver from phenylacetate (a side product of phenylalanine catabolism) and glutamine (which equilibrates with liver glutamate and {alpha}-ketoglutarate). The 14C- or 13C-labeling pattern of the glutamate moiety of phenylacetylglutamine can be measured by sequential degradations to 14CO2, gas chromatography-mass spectrometry or nuclear magnetic resonance (NMR). When phenylacetylglutamine is labeled from singly labeled [14C]- or [13C]substrates, relative metabolic rates can be computed from the labeling pattern using Landau’s model. In diabetic patients infused with [3-13C]pyruvate, the noninvasive sampling of hepatic glutamate via phenylacetylglutamine allows one to test the degree of liver insulinization via the (pyruvate carboxylase)/(pyruvate dehydrogenase) activity ratio. This ratio regulates gluconeogenesis in part. Its measurement may allow the identification of patients who might benefit from the intraperitoneal administration of insulin, or from recently developed antidiabetic drugs.


KEY WORDS: • phenylacetylglutamine • gluconeogenesis • tricarboxylic acid cycle • isotopic methods • diabetes




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. A. Wong, S. Bassilian, S. Lim, and W.-N. Paul Lee
Coordination of Peroxisomal {beta}-Oxidation and Fatty Acid Elongation in HepG2 Cells
J. Biol. Chem., October 1, 2004; 279(40): 41302 - 41309.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]